Looking for an adrenaline-pumping crime drama to binge-watch over the weekend? Channel 4 has got you covered. The glossy, high-stakes Spanish drama, Marbella, arrives on the streaming platform on ...

Puerto Banús, Marbella—among southern Spain's most magnetic marinas. In its 60-year or so trajectory from unassuming southern Spanish fishing village to beach retreat for the rich and famous (though ...

Visitor numbers are down in Marbella as holidaymakers cut back on expensive breaks, with tourists from one country in particular staying away. Marbella, in the south of Spain, has long been etched ...

Amid the buzzy bars and nightclubs of the Costa del Sol is a chic new shopping mall catering to locals and visitors seeking fun while the sun still shines. Marbella’s Golden Mile, an avenue stretching ...

Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, announced that the first patient has been ...

Auron Therapeutics has dosed the first subject in the multicentre Phase I trial of the orally available lysine acetyltransferase 2A (KAT2A) and lysine acetyltransferase 2B (KAT2B) degrader, AUTX-703, ...

The Magic: The Gathering – Final Fantasy crossover launches June 13, 2025, with pre-releases starting June 6, 2025. The set will include Play Boosters, Commander Decks, and Collector Boosters ...

Jekaterina Beljankova is CEO and owner of WALLACE s.r.o, a company specializing in real estate investment in Europe. The European luxury real estate market has long been a magnet for affluent ...

Initiating Clinical Development in Patients with Hematologic Malignancies in the First Quarter of 2025 NEWTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. For Marbella’s most recent residents, one primary hub is not a designer beach club or Michelin-starred ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Auron Therapeutics has raised a $27 million Series B ...